Medtech firm Neurent expands Galway hub

The company is a leader in ear, nose, and throat (ENT) healthcare solutions
Medtech firm Neurent expands Galway hub

Neurent Medical CEO Brian Shields with Minister of State Hildegarde Naughton, and Enterprise Ireland chief executive designate Jenny Melia at the announcement that 125 new jobs will be created in Galway.

Healthcare company Neurent Medical is to create dozens of new jobs in Galway at its new manufacturing facility at Westlink Commercial Park in Oranmore.

The company is a leader in ear, nose, and throat (ENT) healthcare solutions and will create positions in engineering, quality control, operations, supply chain at the new facility, over the next three years. The Galway headquarters will serve as a hub for production of the company’s Neuromark treatment option to treat chronic rhinitis. 

Between the jobs in Galway and sales and marketing roles based in the US, the company will create 125 jobs.

'We’re proud to scale our operations in Galway, where the medtech ecosystem continues to thrive. Our new Westlink facility gives us the manufacturing capacity to meet growing demand for Neuromark, while creating high skilled employment opportunities and contributing to economic vitality in the west of Ireland," said Neurent Medical chief Brian Shields. 

Neurent's Neuromark system recently received US FDA 510(k) clearance, which paves the way for broader commercialisation of its product in the US. 

"Neurent Medical has experienced impressive growth in a short period of time beginning its journey through the BioInnovate Ireland Programme here in Galway with further support awarded through EI’s Commercialisation fund programme and through the Disruptive Technologies Innovation Fund administered by Enterprise Ireland for the development of the Neuromark technology,” said incoming Enterprise Ireland chief Jenny Melia. 

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited